問卷

TPIDB > Principal Investigator

Principal Investigator


National Taiwan University Hospital (在職)

Digestive System Department

更新時間:2025-03-10

邱瀚模CHIU, HAN-MO
  • Co-Principal Investigator
  • Clinical Trial Experience (year) 12 years 9 個月

Publication

56Publications

21

Dekker E, Chiu HM, Lansdorp-Vogelaar I; WEO Colorectal Cancer Screening Committee. Colorectal Cancer Screening in the Novel Coronavirus Disease-2019 Era. Gastroenterology. 2020 Dec;159(6):1998-2003. doi: 10.1053/j.gastro.2020.09.018. Epub 2020 Sep 20. PMID: 32966824; PMCID: PMC7502254.

22

Ho TW, Tsai HH, Lai JF, Chu SM, Liao WC, Chiu HM. Physical fitness cognition, assessment, and promotion: A cross-sectional study in Taiwan. PLoS One. 2020 Oct 6;15(10):e0240137. doi: 10.1371/journal.pone.0240137. PMID: 33022002; PMCID: PMC7537908.

23

Hsu WF, Chang CY, Chang CC, Chang LC, Chen CH, Lin CC, Lin YM, Lee CL, Wu HY, Lee HC, Lee YC, Su MY, Lin LJ, Chia SL, Wu MS, Chiu HM; Colonoscopy Quality Assurance Joint Working Group of Taiwan Colorectal Cancer Screening Program and Digestive Endoscopy Society of Taiwan. Risk of colonoscopy-related complications in a fecal immunochemical test-based population colorectal cancer screening program. Endoscopy. 2022 Mar;54(3):290-298. doi: 10.1055/a-1328-5126. Epub 2021 Feb 24. PMID: 33271603.

24

Hsu WF, Cheng SY, Shun CT, Chang LC, Tu CH, Wang HP, Wu MS, Chiu HM. Higher risk of advanced histology in adenoma less than 10 mm in fecal immunochemical test screening: Implication for management. J Gastroenterol Hepatol. 2020 Oct;35(10):1738-1745. doi: 10.1111/jgh.15040. Epub 2020 Apr 3. PMID: 32187748.

25

Hsu WF, Hsu CY, Yen AM, Chen SL, Chiu SY, Fann JC, Lee YC, Chiu HM, Chen HH. Classifying interval cancers as false negatives or newly occurring in fecal immunochemical testing. J Med Screen. 2021 Sep;28(3):286-294. doi: 10.1177/0969141320986830. Epub 2021 Jan 18. PMID: 33461420.

26

Iwatate M, Hirata D, Francisco CPD, Co JT, Byeon JS, Joshi N, Banerjee R, Quach DT, Aye TT, Chiu HM, Lau LHS, Ng SC, Ang TL, Khomvilai S, Li XB, Ho SH, Sano W, Hattori S, Fujita M, Murakami Y, Shimatani M, Kodama Y, Sano Y; CATCH project team. Efficacy of international web-based educational intervention in the detection of high-risk flat and depressed colorectal lesions higher (CATCH project) with a video: Randomized trial. Dig Endosc. 2022 Sep;34(6):1166-1175. doi: 10.1111/den.14244. Epub 2022 Mar 14. PMID: 35122323; PMCID: PMC9540870.

27

Jen GH, Yen AM, Hsu CY, Chiu HM, Chen SL, Chen TH. Modelling the impacts of COVID-19 pandemic on the quality of population-based colorectal cancer screening. Prev Med. 2021 Oct;151:106597. doi: 10.1016/j.ypmed.2021.106597. Epub 2021 Jun 30. PMID: 34217416; PMCID: PMC8241682.

28

Jen HH, Wang TH, Chiu HM, Peng SM, Hsu CY, Chiu SY, Chen SL, Yen AM, Lee YC, Chen HH, Fann JC. Hurdle Poisson Regression Model for Identifying Factors Related to Noncompliance and Waiting Time for Confirmatory Diagnosis in Colorectal Cancer Screening. Int J Technol Assess Health Care. 2019 Jan;35(2):85-91. doi: 10.1017/S0266462319000047. Epub 2019 Mar 1. PMID: 30819270.

29

Ku MS, Liu CY, Hsu CY, Chiu HM, Chen HH, Chan CC. Association of Ambient Fine Particulate Matter (PM2.5) with Elevated Fecal Hemoglobin Concentration and Colorectal Carcinogenesis: A Population-Based Retrospective Cohort Study. Cancer Control. 2021 Jan-Dec;28:10732748211041232. doi: 10.1177/10732748211041232. PMID: 34525876; PMCID: PMC8450689.

30

Kuo CY, Chiu HM. Application of artificial intelligence in gastroenterology: Potential role in clinical practice. J Gastroenterol Hepatol. 2021 Feb;36(2):267-272. doi: 10.1111/jgh.15403. PMID: 33624890.